There is relatively little research on the anticancer activity of ATL III, which mainly inhibits cancer cell proliferation and promotes apoptosis primarily through the JAK3/STAT3 and miR-195-5p/FGFR1 signaling pathways to treat colon, gastric, lung, and liver cancers. Here, STAT3 is linked to cancer.